Table 1.
Canonical Pathways Observed in Cluster 1 (Top 10 of 20), Characterizing Proteins With Lower Expression at Four Observed Developmental Days (47, 108, 122, and 137) in Comparison to Adult Tissue
| Canonical pathways | P | Proteins |
|---|---|---|
| Acute phase response signaling | 4.37E-07 | PLG, HPX, FN1, C3, SERPINF1, CP, SERPINA3 |
| Caveolar-mediated endocytosis signaling | 4.90E-05 | HLA-A, ITGAV, CAV1, PTRF |
| Neuroprotective role of THOP1 in Alzheimer's disease | 2.75E-04 | PLG, HLA-A, SERPINA3 |
| Hepatic fibrosis/hepatic stellate cell activation | 1.74E-03 | FN1, COL6A1, COL6A3, COL12A1 |
| Coagulation system | 4.17E-03 | PLG, SERPINC1 |
| Complement system | 4.90E-03 | C3, CFH |
| LXR/RXR activation | 5.25E-03 | HPX, C3, SERPINF1 |
| FXR/RXR activation | 6.46E-03 | HPX, C3, SERPINF1 |
| Serotonin receptor signaling | 9.77E-03 | MAOB, SPR |
| Glioma invasiveness signaling | 1.12E-02 | PLG, ITGAV |